Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of L-glutamic acid in a type 2 diabetes animal model

Endocrine

Volumn 16, Issue 2, 2001, Pages 113-116

  Cancelas, Jesús ^a   Villanueva Peñacrrillo, María L ^a   Valverde, Isabel ^a   Malaisse, Willy J ^b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Glucagon like peptide 1; Insulin secretion; L glutamic acid; Methyl pyruvate

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUTAMIC ACID DIMETHYL ESTER; METHYLPYRUVATE; PYRUVIC ACID DERIVATIVE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; DRUG MECHANISM; DRUG POTENTIATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE ACTION; HORMONE RELEASE; INSULIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0035720543     PISSN: 1355008X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ENDO:16:2:113     Document Type: Article

References (15)